Description
DAPT can inhibit gamma-secretase with IC50 of 20 nM.
Storage
2 years at -20centigrade Powder
Molecular Formula
C23H26F2N2O4
Chemical Name
(S)-tert-butyl 2-((S)-2-(2-(3,5-difluorophenyl)acetamido)propanamido)-2-phenylacetate
Solubility
DMSO 87 mg/mL Water
In vitro
DAPT, (N-{N-[2-(3,5-Difluorophenyl)acetyl]-(S)-alanyl}-(S)-phenylglycine tert-butyl ester), is a inhibitor of gamma-secretase( IC50=20 nM), which is involved in Alzheimers disease. DAPT also can inhibit cdk5. Its interesting that DAPT attenuated activity of CDK5, but DAPT can up-regulate the level of CDK5. DAPT can disrupt cdk5 and p35 interaction. DAPT up-regulated neurogenin that is negatively regulated by Notch, and down-regulated Hes1, a downstream target of Notch.
In vivo
Neurons treated with 10 microM DAPT showed attenuated cdk5 activity in spite of an up-regulation of cdk5 protein level, consistent with a phenomenon reported in the cdk5 transgenic mice. In U87MG xenograft mouse models, DAPT treatment increased tumor vessel density but compromised vessel function, as evidenced by poor perfusion and aggravated hypoxia.
Download Datasheet